RUNX2 and myelodysplastic syndrome: Recently, we identified polyploid giant cells expressing CD61, Syncytin-1, telomerase, Runx2, and macrophage markers (CD11b, CD68, and CD163) in the circulation of patients with myelodysplastic syndromes (MDS) [35].